Antibody production
-
Antibody productionWill a single COVID-19 drug be enough to treat all patients?
Philippe Funfrock
As more and more biotherapeutics enter the early stages of clinical development, scientists are questioning if current approaches will be sufficient to curb the pandemic. On the one hand, anti-inflammatory…
-
Will camelid antibodies offer a solution to solve the COVID-19 pandemic?
The emergence of the zoonotic pathogen, SARS-CoV-2, resulted in a global pandemic and caused the deaths of hundreds of thousands… Read More
-
What are chimeric antibodies?
Considered by many researchers as intermediate molecules, chimeric antibody constructs have been gradually losing ground to more effective molecules such… Read More
-
Fully human antibodies that will make the news in 2020
As the demand for fully human antibodies continues to rise, so does the proportion of clinical approvals of this type… Read More
-
Why humanized antibody production may thrive in the 2020s
For the first time, humanized and fully human antibodies are almost on equal terms. Up to 2019, 38 humanized antibodies… Read More
-
Antibody production: rabbit versus mouse, which host best fits your project?
In recent years, rabbit monoclonal antibody production using phage display has been sought after by researchers and industry leaders… Read More
-
Antibody therapeutics in clinical trials for the treatment of COVID-19
The race for the repurposing and development of treatments for COVID-19 continues amidst conflicting data on the new strain of… Read More
-
COVID-19 antibodies, antigens, and services
SARS-CoV-2 is a new Betacoronavirus responsible for the COVID-19 respiratory outbreak. The virus is also the third of the genus… Read More
-
How is antibody therapy changing the way we treat HIV?
The ever-elusive cure for human immunodeficiency virus (HIV) infection continues to be out of reach for most patients. But the… Read More
-
“Researchers are not leveraging the speed and resolution of flow cytometry for clinical evaluation”
Uniquely poised between research labs and the clinic, Professor Tomáš Kalina and his team at the Charles University in Prague,… Read More
